Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Specialized Medical Co's revenue for the
three
months ended in Jun. 2026 was ﷼401 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼1,572 Mil.
Specialized Medical Co's Revenue per Share for the
three
months ended in Jun. 2026 was ﷼1.61.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼6.29.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Specialized Medical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Specialized Medical Co Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Specialized Medical Co's Revenue distribution charts can be found below:
* The bar in red indicates where Specialized Medical Co's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼1,572 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Specialized Medical Co (SAU:4019) has a Revenue of ﷼1,572 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Specialized Medical Co and its competitors.
Is Specialized Medical Co's Revenue too high?
Specialized Medical Co's current Revenue is ﷼1,572 Mil. Overall, Specialized Medical Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Specialized Medical Co's Revenue compare to HCA and THC?
Specialized Medical Co's Revenue of ﷼1,572 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Specialized Medical Co and its competitors. Specialized Medical Co's current Revenue is ﷼1,572 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Specialized Medical Co stock overvalued right now?
Specialized Medical Co (SAU:4019) has a current Revenue of ﷼1,572 Mil. The current Revenue is ﷼1,572 Mil. Specialized Medical Co's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Specialized Medical Co (SAU:4019), the current Revenue is ﷼1,572 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Specialized Medical Co is a full-service healthcare provider, offering a broad range of specialized medical services that encompass the entire healthcare value chain. The healthcare services provided by the company include ambulance services, cardiology, internal medicine, family medicine, and pediatrics. The company also offers surgical services, including general surgery, orthopedics, otorhinolaryngology, gynecological procedures, spinal surgery, obesity surgeries, and all general and specialized surgeries, supported by an integrated network of ancillary departments such as laboratories, diagnostic radiology, nuclear medicine services, anesthesia departments, internal pharmacies, physical therapy services, and nutritional consultations.
13GF Score
Get the complete analysis for SAU:4019
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4019 has been successfully added to your 
